Literature DB >> 32848032

IRF4 Expression Is Required for the Immunoregulatory Activity of Conventional Type 2 Dendritic Cells in Settings of Chronic Bacterial Infection and Cancer.

Xiaozhou Zhang1, Mariela Artola-Boran1, Angela Fallegger1, Isabelle C Arnold1, Achim Weber1,2, Sebastian Reuter3, Christian Taube3, Anne Müller4.   

Abstract

The lamina propria of the gastrointestinal tract and other mucosal surfaces of humans and mice host a network of mononuclear phagocytes that differ in their ontogeny, surface marker and transcription factor expression, and functional specialization. Conventional dendritic cells (DCs) in particular exist as two major subpopulations in both lymphoid and nonlymphoid organs that can be distinguished based on their surface marker and transcription factor expression. In this study, we show in various Th1- and/or Th17-polarized settings of acute and chronic bacterial infection and of tumor growth that the conditional ablation of Irf4 in CD11c+ DCs results in more efficient immune control of Helicobacter pylori, Mycobacterium bovis bacillus Calmette-Guérin, and Citrobacter rodentium and of tumor growth in a syngeneic tumor model. We attribute the phenotype of IRF4ΔDC mice to unrestricted Th1 responses and in particular to IFN-γ- and TNF-α-expressing CD4+ T cells. This activity of IRF4-expressing DCs is linked to a DC-specific immunoregulatory transcriptional program. In contrast, in Th2-polarized settings such as house dust mite-induced allergic airway inflammation, the lack of IRF4 expression in the DC compartment alleviates inflammation and goblet cell metaplasia. The combined data provide evidence for immunoregulatory properties of this versatile DC population in Th1-polarized infection settings.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32848032     DOI: 10.4049/jimmunol.2000405

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

Review 1.  Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.

Authors:  Maggie Musick; Xianzhong Yu
Journal:  Immunol Res       Date:  2022-04-29       Impact factor: 4.505

Review 2.  The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity.

Authors:  Yasuyuki Saito; Satomi Komori; Takenori Kotani; Yoji Murata; Takashi Matozaki
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

3.  Role of Cholinergic Anti-Inflammatory Pathway in Protecting Sepsis-Induced Acute Lung Injury through Regulation of the Conventional Dendritic Cells.

Authors:  Haiyan Huang; Xiaojing Zou; Hong Qi; Hong Liu; You Shang; Ruiting Li; Xuemei Hu; Huibin Chen; Yue Zhao; Xuehui Gao; Yin Yuan; Huiling Guo
Journal:  Mediators Inflamm       Date:  2022-01-27       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.